CollPlant wins Israeli grant for BioInk 3D printed organs

Regenerative medicine company CollPlant said today it received agrant from the Israel Innovation Authority to help support its plant-based rhCollagen technology for tissue repairs. The grant will specifically support uses of its rhCollagen-based formulations intended for use as BioInk for 3D printing tissues and organs, the company said. The total budget for the program $1.2 million (NIS 4.2 million), of which the grant will finance 30% of, subject to certain conditions. Terms of the grant will require that CollPlant pay royalties to the IIA on future sales of technology developed with the funds, up to the full grant amount, CollPlant said. “In addition to providing immediate non-dilutive funding, this grant from the Israel Innovation Authority represents an important validation of our BioInk technology and its market potential. With the recent opening of our new cGMP production facility in Rehovot, Israel, we are well positioned to meet growing demand for our BioInk and tissue repair products. We are grateful to the IIA for this recognition,” CEO Yehiel Tal said in a press release. Last September, CollPlant said it inked a $5 million private placement deal to support its tissue repair technology. The post CollPlant wins Israeli grant for BioInk 3D printed organs appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Regenerative Medicine Research & Development CollPlant Source Type: news

Related Links:

Authors: Chen Z, Chen Q, Du H, Xu L, Wan J Abstract The present study intended to observe the homing capability and therapeutic effect of CXC chemokine receptor 4 (CXCR-4) gene overexpressed bone marrow mesenchymal stem cells (BMSCs) on colitis, and to study the possible mechanisms involved. BMSCs were derived from male BALB/c mice and CXCR-4 gene was transfected into BMSCs by the utilization of the lentiviral vector. The expression of CXCR-4 gene was analyzed and the biological characteristics, and vitality of BMSCs and CXCR-4 gene overexpressed BMSCs (CXCR-BMSCs) were detected. The chemotaxis assay was performed ...
Source: Experimental and Therapeutic Medicine - Category: General Medicine Tags: Exp Ther Med Source Type: research
ConclusionsWe concluded that enhancement of the cytotoxicity to CDDP by coadminstration with DMC was mediated by down-regulation of the expression of TP and ERCC1, regulated by PI3K-Akt-Snail pathway inactivation.Graphical abstract
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research
The objective of this study was to evaluate the regenerative effects of implanted electrodes with different contacts in resected sciatic nerve. Sciatic nerve resection and microsurgical repair models were established and randomly divided into four groups (point contact, 1/4 circle contact; whole-circle contact; no electrodes as control). Electrical stimulation was performed and electrophysiological, morphological and histological exams (of the sciatic nerve and muscle) were conducted at 4 and 10 weeks post-implantation. Point and 1/4 circle contact groups showed significantly higher scores in the sciatic functional index (...
Source: Neuroscience Research - Category: Neuroscience Source Type: research
Publication date: Available online 21 May 2018Source: Journal of Molecular BiologyAuthor(s): Daehyung Kim, Richard Fishel, Jong-Bong LeeAbstractDNA mismatch repair (MMR) corrects DNA base-pairing errors that occur during DNA replication. MMR catalyzes strand-specific DNA degradation and resynthesis by dynamic molecular coordination of sequential downstream pathways. The temporal and mechanistic order of molecular events is essential to insure interactions in MMR that occur over long distances on the DNA. Biophysical real-time studies of highly conserved components on mismatched DNA have shed light on the mechanics of MMR. ...
Source: Journal of Molecular Biology - Category: Molecular Biology Source Type: research
Publication date: Available online 17 August 2018Source: Mutation Research/Reviews in Mutation ResearchAuthor(s): Susanne Burdak-Rothkamm, Kai RothkammAbstractThis review summarises our current understanding of the radiation-induced bystander/systemic effect (RIBE) as well as other types of intercellular reactions induced by malignant tumours, chemotherapy, photodynamic stress and the microbiome. On the basis of striking similarities between these different types of responses RIBE is proposed as a prototype model of a unifying genotoxic stress response system.The early bystander response is initiated by a mitochondria-depe...
Source: Mutation Research Reviews in Mutation Research - Category: Genetics & Stem Cells Source Type: research
ConclusionConcurrent prolapse repair should be performed at the same time as gynecologic cancer surgery.
Source: International Urogynecology Journal - Category: OBGYN Source Type: research
What is the Cliffside Malibu approach? Cliffside Malibu has a evidence-based, well thought out three-fold approach to addiction treatment that creates the foundation for lasting recovery that is different from AA. When all three are used together, the outcomes are more effective than any individual part on its own. Those three approaches are: Intensive one-on-one psychotherapy using the Stages of Change model. Complement intensive therapy with carefully chosen, evidence-based holistic treatments. We employ the first two tools together to create changes in the brain consistent with the ways neuroscience research suggests...
Source: Cliffside Malibu - Category: Addiction Authors: Tags: Addiction Addiction Recovery Addiction Treatment and Program Resources Alcohol Rehab Information Alcoholism Complementary Therapies Drug Rehab Information Drug Treatment Relationships Sober Living and Aftercare Spirituality Substance Source Type: blogs
The Life Extension Advocacy Foundation (LEAF) volunteers recently interviewed Didier Coeurnelle of the Healthy Life Extension Society (HEALES), a long-standing advocate on the European side of our community who has promoted research and development of therapies to treat aging for many years now. Insofar as the treatment of aging goes, we are living through the early stages of an enormously important transition, a tipping point in the progress of medicine. It will be of far greater impact than the advent of antibiotics. The development of rejuvenation therapies, treatments that can reverse or repair or bypass the kno...
Source: Fight Aging! - Category: Research Authors: Tags: Activism, Advocacy and Education Source Type: blogs
Dermatological device developer Kleresca said yesterday it won CE Mark approval in the European Union for its biophotonic dermatological technology platform. The Kleresca biophotonic system uses fluorescent light energy to stimulate biological processes and repair mechanisms in the skin, the company said. Kleresca said that hte clearance will allow it to “consolidate its business on the European market as an independent company and paves the way for future market actirivites in the US, Australia and Canada.” The company added that it expects to apply the Medical Deisng Single Audit Program on top of the CE Mark...
Source: Mass Device - Category: Medical Devices Authors: Tags: Cosmetic/Aesthetic Regulatory/Compliance kleresca Source Type: news
A large number of clinical trials have shown stem cell therapy to be a promising therapeutic approach for the treatment of cardiovascular diseases. Since the first transplantation into human patients, several stem cell types have been applied in this field, including bone marrow derived stem cells, cardiac progenitors as well as embryonic stem cells and their derivatives. However, results obtained from clinical studies are inconsistent and stem cell-based improvement of heart performance and cardiac remodeling was found to be quite limited. In order to optimize stem cell efficiency, it is crucial to elucidate the underlyin...
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
More News: Budgets | Funding | Gastroschisis Repair | Grants | Israel Health | Medical Devices | Middle East Health